Covid-19 registry for atopic dermatitis patients (SECURE-AD)

Have any of your patients with atopic dermatitis developed COVID-19?

Please report your cases to SECURE-AD ( via a simple anonymised case report form. 

SECURE-AD is a global registry for healthcare professionals to report outcomes of COVID-19 in individuals with atopic dermatitis. 

Entering your cases is quick and can be done during a virtual consultation. All data is de-identified.

The information you provide will rapidly improve our understanding of how factors such as systemic immunomodulatory therapies, comorbidities and disease activity affect outcomes of COVID-19 in atopic dermatitis. Regular open-access summaries of reported cases will be provided online. 

SECURE-AD is closely aligned with other Covid-19 skin disease registries, such as SECURE-Alopecia ( and PsoProtect ( and comparative analyses are planned.

We look forward to working with you all on this important international effort. 

Alan Irvine, Phyllis Spuls, and Carsten Flohr (on behalf of the SECURE-AD Steering Group)

Alain Taieb and Andreas Wollenberg (on behalf of the SECURE-AD Scientific Advisory Committee)

Written by


Dermatologist, ErasmusMC Rotterdam, The Netherlands